Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 316–330 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5309 C1QA Gene C1q Deficiency Genetic Test This test identifies pathogenic variants in the C1QA gene using Next-Generation Sequencing (NGS). It confirms or rules out genetic causes of C1q deficiency.	Whole Blood (EDTA tube, 3–5 mL), Extracted DNA (≥200 ng, TE buffer), or Dried Blood Spot on FTA Card	3 to 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C1QA gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number alterations"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}] Preparation ["Mandatory Pre-Test Genetic Counselling", "Clinical History Submission", "Medication & Supplement Disclosure"] Indications ["Suspected C1q deficiency", "Family history of C1q deficiency", "Recurrent infections", "Autoimmune disorders", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 94222-3 ICD-10: D84.1 Clinical summary This test identifies pathogenic variants in the C1QA gene using Next-Generation Sequencing (NGS). It confirms or rules out genetic causes of C1q deficiency.
TEST-5345 C2 Deficiency (C2 Gene) Next-Generation Sequencing Test This test identifies pathogenic variants in the C2 gene, which encodes the complement component 2 protein.	Blood (Whole Blood)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C2 gene", "Complement component 2 protein encoding"] Parameters [] Preparation [] Indications ["Suspected C2 deficiency", "Recurrent infections", "Autoimmune disorders", "Family history of C2 deficiency"] Measurement technique Confirm with laboratory Codes LOINC: 94226-8 ICD-10: D84.1 Clinical summary This test identifies pathogenic variants in the C2 gene, which encodes the complement component 2 protein.
TEST-3586 C21orf2 Gene Cone-Rod Dystrophy Genetic Test This genetic test analyzes the C21orf2 gene and associated retinal genes for pathogenic variants linked to cone-rod dystrophy.	Whole blood or DNA FTA card	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in C21orf2 gene", "Pathogenic variants in 30+ associated retinal genes"] Parameters [] Preparation [] Indications ["Suspected cone-rod dystrophy", "Family history of inherited retinal disease", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: H35.53 Clinical summary This genetic test analyzes the C21orf2 gene and associated retinal genes for pathogenic variants linked to cone-rod dystrophy.
TEST-2464 C2CD3 Gene Orofaciodigital Syndrome Type 14 Genetic Test This diagnostic test evaluates for pathogenic variants within the C2CD3 gene associated with Orofaciodigital Syndrome Type 14.	Peripheral Whole Blood / Dried Blood Spot (DBS)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["C2CD3 gene mutations", "Point mutations", "Indels", "Copy-number variants"] Parameters [] Preparation [] Indications ["Individuals with clinical features suggestive of OFD14", "Families with a history of syndromic congenital conditions"] Measurement technique Confirm with laboratory Codes LOINC: 95039-2 ICD-10: Q87.0 Clinical summary This diagnostic test evaluates for pathogenic variants within the C2CD3 gene associated with Orofaciodigital Syndrome Type 14.
TEST-5396 C4orf26 Gene Amelogenesis Imperfecta Type 2A4 Genetic Test This test identifies disease-causing mutations in the C4orf26 gene associated with Amelogenesis Imperfecta Type 2A4.	Whole blood, extracted DNA, dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["C4orf26 gene sequence", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["No special fasting required", "Pre-test genetic counselling session is mandatory"] Indications ["Suspected Amelogenesis Imperfecta Type 2A4", "Hereditary enamel defects"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: K00.5, Z31.430 Clinical summary This test identifies disease-causing mutations in the C4orf26 gene associated with Amelogenesis Imperfecta Type 2A4.
TEST-5299 C7 Gene Deficiency Genetic Test This test identifies pathogenic variants in the C7 gene associated with hereditary complement component 7 deficiency.	Whole Blood (EDTA tube) or FTA Card (Dried Blood Spot)	14–21 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C7 gene", "SNVs, indels, CNVs"] Parameters [] Preparation ["None specified"] Indications ["Suspected hereditary complement component 7 deficiency", "Family history of C7 deficiency", "Recurrent severe infections"] Measurement technique Confirm with laboratory Codes LOINC: 95275-6 ICD-10: D84.1 Clinical summary This test identifies pathogenic variants in the C7 gene associated with hereditary complement component 7 deficiency.
TEST-3886 C7orf43 Gene Autism Genetic Test This test evaluates the C7orf43 gene for pathogenic variants associated with autism spectrum disorder.	Venous Whole Blood, Dried Blood Spot (FTA Card), or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the C7orf43 gene", "Single nucleotide variants", "Small indels"] Parameters [] Preparation ["Genetic counselling session required before sample collection", "Detailed clinical history and pedigree chart needed"] Indications ["Diagnosis of autism spectrum disorder", "Identification of genetic factors contributing to neurodevelopmental conditions"] Measurement technique Confirm with laboratory Codes LOINC: 21636-1 ICD-10: F84.0 Clinical summary This test evaluates the C7orf43 gene for pathogenic variants associated with autism spectrum disorder.
TEST-3795 C9orf72 Gene Amyotrophic Lateral Sclerosis with Frontotemporal Dementia Genetic Test This test identifies pathological hexanucleotide repeat expansions in the C9orf72 gene, a primary genetic cause of familial ALS and FTD.	Peripheral whole blood	3–4 Weeks (expedited option available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Hexanucleotide repeat expansions in the C9orf72 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions"] Indications ["Suspected familial ALS", "Suspected familial FTD", "Evaluation of genetic risk for ALS/FTD"] Measurement technique Confirm with laboratory Codes LOINC: 90520-1 ICD-10: G12.22, F02.80 Clinical summary This test identifies pathological hexanucleotide repeat expansions in the C9orf72 gene, a primary genetic cause of familial ALS and FTD.
TEST-6209 CA12 Gene Hyperchlorhidrosis, Isolated Genetic Test This test evaluates the entire coding region of the CA12 gene for variants associated with isolated hyperchlorhidrosis.	Whole Blood (PBMC) or Dried Blood Spot on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CA12 gene variants", "Sweat chloride regulation pathway"] Parameters [] Preparation ["Pre-test genetic counselling required", "Provide a three-generation family pedigree"] Indications ["Definitive diagnosis of isolated hyperchlorhidrosis", "Family screening for CA12 variants", "Genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 48000-0 ICD-10: E88.8 Clinical summary This test evaluates the entire coding region of the CA12 gene for variants associated with isolated hyperchlorhidrosis.
TEST-4694 CA2 Gene Osteopetrosis (Autosomal Recessive Type 3) Genetic Test This test identifies mutations in the CA2 gene associated with autosomal recessive osteopetrosis type 3.	Whole blood, extracted DNA, or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CA2 gene mutations", "DNA sequence variants"] Parameters [] Preparation [] Indications ["Suspected autosomal recessive osteopetrosis type 3", "Family planning for carrier couples", "Evaluation of bone fragility"] Measurement technique Confirm with laboratory Codes LOINC: 55132-0 ICD-10: Q78.2 Clinical summary This test identifies mutations in the CA2 gene associated with autosomal recessive osteopetrosis type 3.
TEST-6211 CA5A Gene Hyperammonemia due to Carbonic Anhydrase VA Deficiency Genetic Test This test identifies pathogenic variants in the CA5A gene associated with hyperammonemia.	Whole blood (EDTA), dried blood spot on FTA card, or extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CA5A gene sequence", "Pathogenic variants in CA5A"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medications"] Indications ["Suspected CA5A deficiency", "Neonatal hyperammonemia", "Family history of urea cycle disorders", "At-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 81748-2 ICD-10: E72.2, E72.8, Z13.228 Clinical summary This test identifies pathogenic variants in the CA5A gene associated with hyperammonemia.
TEST-4012 CA8 Gene Test for Cerebellar Ataxia & Mental Retardation (CAMRQ3) This genetic test identifies mutations in the CA8 gene associated with Cerebellar Ataxia, Mental Retardation, and Dysequilibrium Syndrome 3 (CAMRQ3). It uses next-generation sequen...	Whole blood (EDTA), extracted DNA, or dry blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CA8 gene variants", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)"] Parameters [] Preparation [] Indications ["Diagnostic confirmation of CAMRQ3", "Carrier testing", "Family risk assessment", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 83006-7 ICD-10: G11.8, F79, Z15.89 Clinical summary This genetic test identifies mutations in the CA8 gene associated with Cerebellar Ataxia, Mental Retardation, and Dysequilibrium Syndrome 3 (CAMRQ3). It uses next-generation sequencing to analyze the entire coding region of the gene.
TEST-5580 CABP2 Gene (Autosomal Recessive Deafness Type 93) Genetic Test This test identifies pathogenic variants in the CABP2 gene associated with autosomal recessive deafness type 93 (DFNB93).	Whole blood (EDTA), extracted DNA, or FTA card	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CABP2 gene", "Presence of mutations associated with DFNB93"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Individuals with congenital or early-onset sensorineural hearing loss", "Family history of hereditary hearing loss", "Consanguinity"] Measurement technique Confirm with laboratory Codes LOINC: 83325-1 ICD-10: H90.3 Clinical summary This test identifies pathogenic variants in the CABP2 gene associated with autosomal recessive deafness type 93 (DFNB93).
TEST-4472 CACNA1A Gene Analysis (Familial Hemiplegic Migraine Type 1) Test This test identifies pathogenic variants in the CACNA1A gene associated with Familial Hemiplegic Migraine Type 1 (FHM1). It uses Next Generation Sequencing (NGS) for comprehensive...	Peripheral Whole Blood or Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1A gene", "Point mutations", "Indels", "Copy number variants"] Parameters [] Preparation [] Indications ["Molecular confirmation of suspected Familial Hemiplegic Migraine Type 1", "Risk assessment for family members of a confirmed FHM1 proband"] Measurement technique Confirm with laboratory Codes LOINC: 94244-1 ICD-10: G43.10 Clinical summary This test identifies pathogenic variants in the CACNA1A gene associated with Familial Hemiplegic Migraine Type 1 (FHM1). It uses Next Generation Sequencing (NGS) for comprehensive analysis.
TEST-5896 CACNA1A Gene Spinocerebellar Ataxia Type 6 (SCA6) Genetic Test This test identifies pathogenic variants within the CACNA1A gene, confirming a diagnosis of autosomal dominant Spinocerebellar Ataxia Type 6 (SCA6).	Whole Blood, Extracted DNA, or One Drop Blood on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CACNA1A gene sequence", "Copy number variations in CACNA1A gene"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}] Preparation ["Pre-test genetic counselling recommended", "Provide detailed clinical history", "No special fasting required", "Inform phlebotomist of anticoagulant therapy"] Indications ["Family history of SCA6", "Suggestive clinical symptoms of SCA6", "Need for definitive molecular confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 82996-8 ICD-10: G11.2 Clinical summary This test identifies pathogenic variants within the CACNA1A gene, confirming a diagnosis of autosomal dominant Spinocerebellar Ataxia Type 6 (SCA6).

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories